Table: RaQualia Pharma -2025 group results

RaQualia Pharma

13/02/2026 06:43

Feb 13 (Reuters)- 
          RaQualia Pharma Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to        NEXT   
                Dec 31, 2025    Dec 31, 2024    Dec 31, 2026     YEAR     
                   LATEST         YEAR-AGO        COMPANY       COMPANY   
                   RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales             3.98            3.11            3.98                  
                 (+28.1 pct)     (+63.5 pct)                              
  Operating        483 mln      loss 213 mln      165 mln                 
                                                (-65.9 pct)               
  Recurring        437 mln      loss 361 mln       86 mln                 
                                                (-80.4 pct)               
  Net
  Net              273 mln      loss 495 mln    loss 63 mln               
  EPS             11.53 yen    loss 22.87 yen  loss 2.58 yen              
  EPS Diluted     11.36 yen                                               
  Ann Div            NIL             NIL            NIL                   
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div            NIL             NIL            NIL                   
  
  NOTE - RaQualia Pharma Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T